Skip to search formSkip to main contentSkip to account menu

SmithKline Beecham

Known as: GlaxoSmithKline 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2017
Highly Cited
2017
BACKGROUND Combination therapy with the BRAF inhibitor dabrafenib plus the MEK inhibitor trametinib improved survival in patients… 
Highly Cited
2011
Highly Cited
2011
Solvents make a large contribution to the environmental impact of manufacturing processes of active pharmaceutical ingredients… 
Highly Cited
2010
Highly Cited
2010
CONTEXT Detectable levels of cardiac troponin T (cTnT) are strongly associated with structural heart disease and increased risk… 
Highly Cited
2010
Highly Cited
2010
Background— Inflammation is a feature of pulmonary arterial hypertension (PAH), and increased circulating levels of cytokines are… 
Review
2009
Review
2009
We appreciate Dr. Woo's response to our study (1) and his comparison (2) of the Canadian Diabetes Association (CDA) clinical… 
Highly Cited
2008
Highly Cited
2008
The Netherlands Study of Depression and Anxiety (NESDA) is a multi‐site naturalistic cohort study to: (1) describe the long‐term… 
Highly Cited
2008
Highly Cited
2008
The consensus algorithm for the medical management of type 2 diabetes was published in August 2006 with the expectation that it… 
Review
2007
Review
2007
The sequencing of the first complete bacterial genome in 1995 heralded a new era of hope for antibacterial drug discoverers, who… 
Review
2007
Review
2007
Highly Cited
2006
Highly Cited
2006
The American Heart Association (AHA) and the American Diabetes Association (ADA) have each published guidelines for…